This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_MALE_GENITAL_EXALLC for full statistics.
malignant neoplasm of male genital organs
C3_MALE_GENITAL
male reproductive organ cancer: A reproductive organ cancer that is manifested in the male genital system. This includes organs such as the penis and scrotum.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
20377 |
6. Filter based on genotype QC (FinnGen only) |
20377 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF4
Similar endpoints
↥List of similar endpoints to
malignant neoplasm of male genital organs
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 20377 | - | 20377 |
| Unadjusted period prevalence (%) | 8.98 | - | 8.98 |
| Median age at first event (years) | 68.93 | - | 68.93 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 11915
- Matched controls
- 83988
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
13.5
323.3
632
346
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
8.9
323.0
1054
908
116
Kela drug reimbursment
Prostate cancer
+∞
323.0
5838
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
1103.2
323.0
863
6
JN4BD
NOMESCO Finland
Extensive body CT
3.5
323.0
2013
4587
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
4.4
323.0
2833
5587
Y77
ICPC
Malignant neoplasm prostate
275.7
323.0
2141
67
L02AE03
ATC
goserelin; implant
732.1
323.0
593
6
KEB00
NOMESCO Finland
Biopsy of prostate
16.8
323.0
652
289
UKC02
NOMESCO Finland
Cystoscopy
2.7
323.0
3187
10127
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
16.8
323.0
3393
1939
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
36.3
323.0
4743
1501
C61
ICD-10 Finland
Malignant neoplasm of prostate
1575.3
323.0
11006
652
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
31.5
323.0
689
163
G04BE03
ATC
sildenafil; oral
36.3
323.0
823
171
ZXC96
NOMESCO Finland
Robot assisted procedure
53.3
323.0
1815
282
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
201.5
323.0
1044
40
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
353.5
323.0
2673
68
TKE00
NOMESCO Finland
Needle biopsy of prostate
13.9
323.0
2285
1409
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
31.6
323.0
1033
251
NK6AN
NOMESCO Finland
Total body bone isotope imaging
73.2
323.0
1371
149
G03HA01
ATC
cyproterone; systemic
121.2
323.0
463
28
L02AE04
ATC
triptorelin; parenteral
3552.2
323.0
491
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
323.0
633
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
6.0
323.0
4702
8266
L02BX02
ATC
degarelix; parenteral
+∞
323.0
821
*
L02BB03
ATC
bicalutamide; oral
2526.4
323.0
2383
8
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
14.4
323.0
772
403
G04CA02
ATC
tamsulosin; oral
2.2
323.0
5473
23535
L02BB04
ATC
enzalutamide; oral
+∞
323.0
500
*
KFC10
NOMESCO Finland
Bilateral orchiectomy
288.0
323.0
397
10
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
80.1
323.0
1271
125
KE1DG
NOMESCO Finland
Very extensive MRI of prostate
18.8
323.0
597
235
XX3DW
NOMESCO Finland
Time consuming IT work
6.2
323.0
2291
3117
WF002
NOMESCO Finland
Radical radiotherapy
19.1
323.0
2410
1097
N40
ICD-10 Finland
Hyperplasia of prostate
2.2
323.0
5235
21891
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
323.0
4289
13729
XKD00
NOMESCO Finland
Uroflowmetry
7.0
323.0
6158
11065
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
4503599627370496.0
323.0
11136
27
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
59.0
323.0
679
86
KE1BG
NOMESCO Finland
MRI of prostate
26.2
323.0
510
143
XJH00
NOMESCO Finland
Transanal ultrasonography
5.6
323.0
2277
3394
L02AE02
ATC
leuprorelin; implant, parenteral
7247.5
323.0
3646
5
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
323.0
3341
9768
J01EA01
ATC
trimethoprim; systemic
3.8
323.0
2565
5710
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
323.0
438
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
177.2
323.0
1340
60
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
14.5
323.0
1353
734
KC1GB
NOMESCO Finland
Cystography with X-ray
54.2
323.0
695
96
J01MA02
ATC
ciprofloxacin; systemic
2.2
312.9
5308
22768
L02BX03
ATC
abiraterone; oral
+∞
305.2
335
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
10.2
301.4
672
488
G04BE01
ATC
alprostadil; parenteral, urethral
7.6
301.2
797
781
M05BX04
ATC
denosumab; parenteral
9.3
288.2
674
535
KDE20
NOMESCO Finland
Removal of foreign body from urethra
21.2
276.0
458
158
ZX070
NOMESCO Finland
Intensity modified radiotherapy
10.2
259.3
579
420
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
14.7
256.4
483
240
1850A
ICD-9 Finland
Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]
217.3
254.5
299
10
WF090
NOMESCO Finland
Profylactic radiotherapy
178.2
249.0
296
12
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
10.8
248.0
537
366
KE1CG
NOMESCO Finland
Extensive MRI of prostate
32.1
247.0
367
83
KFC00
NOMESCO Finland
Unilateral orchiectomy
18.0
238.4
417
169
WF003
NOMESCO Finland
Adjuvant radiotherapy
7.7
236.2
621
598
TKE10
NOMESCO Finland
Puncture of prostate
80.6
236.1
301
27
ZX090
NOMESCO Finland
Other technic of radiotherapy
9.0
233.2
554
450
K62.7
ICD-10 Finland
Radiation proctitis
304.8
220.7
255
6
N39.3
ICD-10 Finland
Stress incontinence
23.2
216.3
349
109
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
42.1
215.8
303
52
JN4AD
NOMESCO Finland
Body CT examination
3.2
212.3
1337
3233
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
27.7
206.8
318
83
L01XX11
ATC
estramustine; systemic
+∞
200.9
221
*
1523
Kela drug reimbursment
NA
+∞
196.4
216
*
3054
Kela drug reimbursment
NA
+∞
196.4
216
*
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
395.7
193.1
221
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
192.8
3199
12909
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
62.8
192.3
253
29
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
90.8
190.9
240
19
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
12.4
187.5
379
222
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
15.2
183.1
340
162
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.1
180.8
650
945
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
35.0
177.2
258
53
B01AB05
ATC
enoxaparin; parenteral
1.9
177.0
3378
14293
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.5
173.7
695
1133
N02BE01
ATC
paracetamol; systemic, rectal
1.9
173.5
9149
53784
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
169.0
186
*
L02BB01
ATC
flutamide; oral
1288.8
167.7
187
*
OAB42
NOMESCO Finland
Guidance related to known health problem
41.7
153.0
215
37
KED22
NOMESCO Finland
Transurethral resection of prostate
2.5
152.9
1380
4136
R31
ICD-10 Finland
Unspecified haematuria
2.2
147.2
1792
6236
WZC30
NOMESCO Finland
Teaching
2.3
146.5
1651
5540
R33
ICD-10 Finland
Retention of urine
2.3
145.8
1566
5132
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
145.5
4456
21708
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
5.7
144.0
468
602
G04BE30
ATC
drugs used in erectile dysfunction - combinations
151.0
140.6
169
8
G04BD12
ATC
mirabegron; oral
2.6
137.2
1132
3214
Y06
ICPC
Prostate symptom/complaint
3.6
137.1
709
1456
ZX080
NOMESCO Finland
Image guided radiotherapy
9.7
135.3
307
228
ZX112
NOMESCO Finland
Subcutaneous
6.6
131.8
379
414
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
1040.6
128.6
144
*
7512
FHL
Orchidectomy (bilateral)
1032.5
127.7
143
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
81.6
125.9
160
14
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
40.8
125.6
177
31
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
331.6
121.6
140
*
H02AB02
ATC
dexamethasone; systemic
2.4
120.2
1137
3469
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
113.0
1904
7504
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
57.9
109.9
146
18
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
108.9
120
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
106.9
4870
25718
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
288.3
105.4
122
*
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
17.4
105.3
185
76
U04
ICPC
Incontinence urine
3.9
104.9
481
888
TQW40
NOMESCO Finland
Remowal of suture of skin
2.6
104.6
851
2379
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.7
104.5
514
1009
Z12.5
ICD-10 Finland
Special screening examination for neoplasm of prostate
8.0
100.2
253
227
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
14.4
98.1
185
92
G04CA01
ATC
alfuzosin; oral
1.7
97.8
2426
10827
G04BD08
ATC
solifenacin; oral
2.7
95.5
730
1964
TKC52
NOMESCO Finland
Patient education concerning pelvic floor contraction exercises
60.0
89.4
118
14
TKC20
NOMESCO Finland
Catheterisation of bladder
2.2
88.3
1064
3627
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
18.1
86.7
150
59
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
6.6
82.7
237
258
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
223.4
81.2
95
*
8000/3-C61.9
ICD-O-3
Neoplasm, malignant of prostate gland
+∞
80.7
89
*
Z51.0
ICD-10 Finland
Radiotherapy session
7.1
80.4
218
219
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
39.8
79.4
112
20
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
33.8
78.2
114
24
ZXC20
NOMESCO Finland
Use of chemical agents
4.6
77.9
298
461
L03AA13
ATC
pegfilgrastim; parenteral
4.1
77.4
333
579
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
304.0
74.5
86
*
WX402
NOMESCO Finland
General anaesthesia
1.8
73.8
1573
6629
2BX02
NOMESCO Finland
NA
+∞
72.5
80
*
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
35.2
72.0
104
21
KDW96
NOMESCO Finland
Other operations on urethra
41.8
71.6
100
17
G04BE09
ATC
vardenafil; oral
66.1
71.5
93
10
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
9.1
71.3
166
130
KE1DR
NOMESCO Finland
Prostate metabolic PET with CT
149.0
70.0
84
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
282.5
69.1
80
*
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
5.0
68.8
243
345
N02AA05
ATC
oxycodone; systemic
1.7
67.3
1673
7373
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.6
67.3
562
1587
HB000
NOMESCO Finland
Profylactic radiotherapy of mammary gland
+∞
67.1
74
*
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
4.1
64.3
277
483
KDG43
NOMESCO Finland
Transobturatorial sling urethrocystopexy
179.8
64.2
76
*
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
21.7
63.9
104
34
KD1GB
NOMESCO Finland
Uretrocystogpaphy with X-ray
15.9
63.2
114
51
R74.9
ICD-10 Finland
Abnormal level of unspecified serum enzyme
8.6
62.6
150
124
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
61.7
68
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
91.0
61.6
77
6
ZX050
NOMESCO Finland
Stereotactic radiotherapy
7.7
60.7
156
145
JN4CD
NOMESCO Finland
Very extensive body CT
2.5
60.5
520
1491
L03AA14
ATC
lipegfilgrastim; parenteral
5.8
60.1
188
231
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.5
59.6
307
626
WF004
NOMESCO Finland
Palliative radiotherapy
3.6
59.4
300
602
XKG00
NOMESCO Finland
Artificial induction of erection
22.5
57.2
92
29
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.6
57.1
475
1336
XX7FT
NOMESCO Finland
Radioyttrium therapy with connected antibody
232.4
56.6
66
*
ZX022
NOMESCO Finland
LDR radiotherapy within tissue
158.2
56.2
67
*
U77
ICPC
Malignant neopl urinary tract other
49.0
56.1
76
11
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
3.6
55.9
278
551
N30.4
ICD-10 Finland
Irradiation cystitis
153.5
54.4
65
*
J01MA12
ATC
levofloxacin; systemic
1.5
54.4
2148
10603
L02AE01
ATC
buserelin; implant, nasal, parenteral
+∞
53.5
59
*
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
53.5
59
*
TKC22
NOMESCO Finland
Catheterisation instruction
3.0
52.0
340
826
A04AA02
ATC
granisetron; systemic, transdermal
2.2
51.8
564
1825
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
20.8
51.7
85
29
R86.1
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of hormones
9.6
51.2
115
85
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
66.8
51.0
66
7
XKD03
NOMESCO Finland
Urethral pressure profilometry
4.8
50.8
188
282
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
402.7
50.0
57
*
Y78
ICPC
Malign neopl male genital other
141.6
50.0
60
*
R86.9
ICD-10 Finland
Abnormal findings in specimens from male genital organs, unspecified abnormal finding
8.3
48.8
119
102
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
4.7
48.7
182
276
Z51.5
ICD-10 Finland
Palliative care
2.0
47.6
690
2522
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
8.2
47.4
116
100
G04BE08
ATC
tadalafil; oral
25.2
45.7
71
20
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
21.0
45.3
74
25
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.8
45.1
166
248
J01MA01
ATC
ofloxacin; systemic
1.7
45.0
1036
4430
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
43.7
538
1836
WX320
NOMESCO Finland
Spinalanesthesy
1.5
43.6
2034
10349
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
10.7
43.4
92
61
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.5
42.8
380
1110
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
120.3
42.0
51
*
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
26.2
41.1
63
17
XX1AD
NOMESCO Finland
Other CT-examination
8.3
41.1
100
86
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
40.8
45
*
A79
ICPC
Malignancy NOS
4.4
40.8
163
266
1CD02
NOMESCO Finland
NA
21.2
40.6
66
22
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
6.1
40.3
121
142
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
25.8
40.3
62
17
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
40.0
4486
26419
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
39.9
1000
4374
KDK10
NOMESCO Finland
Implantation of artificial urinary sphincter around bulbar urethra
47.8
39.9
54
8
WF099
NOMESCO Finland
Other radiotherapy
8.3
39.6
96
82
D07.5
ICD-10 Finland
Carcinoma in situ: Prostate
70.8
39.1
50
5
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
6.8
39.0
107
111
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
10.7
37.9
80
53
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
8.3
37.5
91
78
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
36.3
1207
5679
XX7AT
NOMESCO Finland
Radiation therapy with Radium-223
+∞
36.2
40
*
KE003
NOMESCO Finland
Adjuvant radiotherapy of prostata and seminal vesicles
+∞
36.2
40
*
N99.1
ICD-10 Finland
Postprocedural urethral stricture
5.1
36.0
123
170
NK6SN
NOMESCO Finland
Bone SPECT
36.1
35.8
51
10
KCC10
NOMESCO Finland
Cystoprostatectomy
5.0
35.7
125
178
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
48.6
35.6
48
7
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
35.3
39
*
L02AA02
ATC
polyestradiol phosphate; parenteral
+∞
35.3
39
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.3
35.1
359
1127
N30.0
ICD-10 Finland
Acute cystitis
1.8
33.7
630
2519
B01AB10
ATC
tinzaparin; parenteral
1.8
33.5
600
2362
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
33.3
2740
15311
KE1DM
NOMESCO Finland
Very extensive MRI of prostate (more than 1.5 T)
45.4
33.0
45
7
G04BD07
ATC
tolterodine; oral
2.1
32.9
413
1424
OAB77
NOMESCO Finland
Discussion on exercise habits and instruction concerning use of sports and fitness services
+∞
32.6
36
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
8.9
32.3
75
60
C60.0
ICD-10 Finland
Malignant neoplasm: Prepuce
50.7
32.2
43
6
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
31.8
975
4491
8070/3-C60.9
ICD-O-3
Squamous cell carcinoma, NOS, of penis, NOS
+∞
31.7
35
*
8010/3-C61.9
ICD-O-3
Carcinoma, NOS, of prostate gland
+∞
31.7
35
*
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
58.0
31.3
41
5
7455
FHL
Retropubic total prostatectomy
42.4
30.5
42
7
J01CA08
ATC
pivmecillinam; oral
1.7
30.4
652
2723
N35.9
ICD-10 Finland
Urethral stricture, unspecified
2.8
30.4
207
520
R39.1
ICD-10 Finland
Other difficulties with micturition
2.1
30.4
392
1367
WX110
NOMESCO Finland
Local anesthesy
1.3
30.1
5857
36540
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
29.9
33
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
29.9
33
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
7.0
29.5
79
80
A28
ICPC
Limited function/disability NOS
1.5
29.2
1301
6512
5BX04
NOMESCO Finland
NA
36.2
28.9
41
8
18699
ICD-8 Finland
Malignant neoplasm of testis
84.8
28.8
36
*
7461
FHL
Needle biopsy in the operating room
4.3
28.3
113
186
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.2
28.1
305
987
KDV10
NOMESCO Finland
Internal urethrotomy
2.7
27.9
206
544
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
2.8
27.7
189
474
KCD02
NOMESCO Finland
Transurethral resection of bladder
2.0
27.1
375
1344
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.7
27.0
668
2904
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
26.9
6225
39385
WVA20
NOMESCO Finland
Medicine administration
2.5
26.4
222
631
XX1XQ
NOMESCO Finland
Other SPECT-CT
113.0
26.4
32
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.8
26.2
457
1787
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
26.1
2225
12428
WVA30
SPAT
NA
2.3
26.0
252
773
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
25.4
28
*
A07EA02
ATC
hydrocortisone; rectal
2.5
25.0
213
610
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.4
25.0
1149
5776
KE1AE
NOMESCO Finland
Percutaneous utlrasound examination fo prostata
5.4
24.8
80
105
UJF32
NOMESCO Finland
Coloscopy
1.3
24.5
2265
12786
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
198.5
24.0
28
*
XKC03
NOMESCO Finland
Water cystometry
2.5
23.9
209
607
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
2.0
23.8
312
1095
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
8.6
23.6
55
45
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
7.9
23.6
58
52
8070/3-C60.1
ICD-O-3
Squamous cell carcinoma, NOS, of glans penis
+∞
23.6
26
*
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
23.2
713
3281
B02AA02
ATC
tranexamic acid; systemic
1.7
23.1
550
2365
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
191.2
23.1
27
*
C05AA08
ATC
fluocortolone; rectal, topical
1.4
23.0
1189
6106
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
11.1
23.0
47
30
D64.9
ICD-10 Finland
Anaemia, unspecified
1.4
22.9
1036
5190
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
22.6
25
*
KEC10
NOMESCO Finland
Perineal radical prostatectomy
+∞
22.6
25
*
G04CB02
ATC
dutasteride; oral
1.5
22.6
988
4916
SPAT1254
SPAT
Administration of medicine
1.4
22.5
1190
6135
J01MA06
ATC
norfloxacin; oral
1.5
22.5
828
3969
U06
ICPC
Haematuria
2.2
22.1
249
822
OAB75
NOMESCO Finland
Nutritional guidance related to maintaining health
36.5
22.1
31
6
KA3EB
NOMESCO Finland
Antegrade pyelography
4.5
22.0
84
133
D40.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Male genital organ, unspecified
8.1
22.0
53
46
SPAT1167
SPAT
Insertion of urinary catheter
1.9
22.0
364
1398
J01DB01
ATC
cefalexin; oral
1.2
22.0
7834
51305
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.3
22.0
1793
9926
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.5
21.9
721
3370
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.9
21.3
141
350
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
2.1
21.2
250
842
R4110
NOMESCO Finland
Physiotherapy
1.3
21.0
2285
13145
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
27.4
20.7
31
8
G04BD11
ATC
fesoterodine; oral
2.2
20.6
217
694
C62
ICD-10 Finland
Malignant neoplasm of testis
169.4
20.4
24
*
K62.8
ICD-10 Finland
Other specified diseases of anus and rectum
4.2
20.4
83
141
ZXA10
NOMESCO Finland
Bilateral
1.3
20.4
1395
7512
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
7.1
20.2
53
53
JGA28
NOMESCO Finland
Endoscopic contact coagulation in rectum
26.5
19.9
30
8
KE099
NOMESCO Finland
Other radiotherapy of prostata and seminal vesicles
+∞
19.9
22
*
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
19.9
22
*
U76
ICPC
Malignant neoplasm of bladder
7.1
19.9
52
52
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.6
19.6
237
2948
KDV20
NOMESCO Finland
Submucous urethral injection
21.9
19.6
31
10
C61, D400
ICD-10 Finland
NA
162.4
19.5
23
*
SPAT1262
SPAT
Handing over of treatment supplies
1.3
19.5
1820
10254
SPAT1053
SPAT
Memory test
1.4
19.4
1172
6178
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
84.7
19.3
24
*
KGC00
NOMESCO Finland
Partial amputation of penis
45.8
19.3
26
*
A04AA01
ATC
ondansetron; systemic, rectal
1.7
19.2
463
1999
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
2.0
19.2
246
860
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
19.0
21
*
-50
ICPC
Medication/prescr/renewal
1.8
18.7
339
1345
Y50
ICPC
Male Genital, Medication/prescr/renewal
8.7
18.7
43
35
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
18.5
931
4752
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
18.4
849
4267
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
14.6
18.3
33
16
WB211
NOMESCO Finland
Neoadjuvant hormone therapy of malignancy
+∞
18.1
20
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
17.9
1649
9261
A06AD11
ATC
lactulose; oral
1.3
17.8
1465
8099
WW500
NOMESCO Finland
Blood transfusion
1.7
17.8
355
1451
Z02.4
ICD-10 Finland
Examination for driving licence
1.2
17.6
2526
14978
A55
ICPC
General and Unspecified, Local injection/infiltration
3.1
17.6
102
233
TQX05
NOMESCO Finland
Skin puncture, unspecified location
7.8
17.6
43
39
U08
ICPC
Urinary retention
2.0
17.5
222
771
U29
ICPC
Urinary symptom/complaint other
2.1
17.4
197
654
S18
ICPC
Laceration/cut
1.2
17.3
3697
22838
SPAT1304
SPAT
Counselling and guidance related to ageing
1.6
17.2
480
2156
A02BC02
ATC
pantoprazole; systemic
1.2
17.0
5919
38191
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
2.3
16.9
159
484
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.3
16.9
1493
8332
UKD02
NOMESCO Finland
Urethroscopy
3.9
16.8
74
136
SPAT1325
SPAT
Vaccination
1.2
16.7
2626
15710
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
16.7
1898
10946
U05
ICPC
Urination problems other
1.7
16.7
375
1589
6000A
ICD-9 Finland
Hyperplasia of prostate[HYPERPLASIA PROSTATAE]
1.7
16.4
339
1401
SPAT1263
SPAT
Sampling
1.2
16.4
3333
20468
KE2KT
NOMESCO Finland
Marker implantation in prostate under radiological guidance
+∞
16.3
18
*
JGA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in rectum
28.2
16.3
24
6
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
16.3
964
5063
U13
ICPC
Bladder symptom/complaint other
2.3
16.2
162
510
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
3.2
16.1
87
190
JN2BM
NOMESCO Finland
Lower part of abdomen MRI examination with Tesla magnet
38.8
16.0
22
*
KDK40
NOMESCO Finland
Removal of artificial urethral sphincter
134.1
16.0
19
*
TKD00
NOMESCO Finland
Dilatation of urethra
3.3
15.9
85
184
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.2
15.9
20
620
ZX100
NOMESCO Finland
Oral
2.4
15.8
137
399
H91.1
ICD-10 Finland
Presbycusis
1.5
15.7
491
2268
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.3
15.6
1341
7455
KE2JT
NOMESCO Finland
Demanding radiation source placement in prostate under ultrasound guidance
+∞
15.4
17
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
15.4
17
*
KEW98
NOMESCO Finland
Other transluminal endoscopic operation on prostate
+∞
15.4
17
*
D29.1
ICD-10 Finland
Benign neoplasm: Prostate
3.4
15.3
77
159
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.3
15.3
1855
10771
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
15.2
8576
57370
7451
FHL
Transurethral adenoma removal
1.9
15.1
249
956
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
2.7
15.1
111
296
R86
ICD-10 Finland
Abnormal findings in specimens from male genital organs
8.6
14.8
34
28
N30.9
ICD-10 Finland
Cystitis, unspecified
1.8
14.8
270
1075
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
14.8
1338
7487
1530
FHL
Urethrocystoscopy
1.8
14.7
246
953
A98
ICPC
Health maint/preventive medicine
1.2
14.7
9199
61990
KE2AT
NOMESCO Finland
Cytologoy of prostata with ultrasound guidance
13.6
14.7
27
14
SPAT1088
SPAT
Blood transfusion
3.8
14.6
64
118
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.8
14.6
250
976
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
14.5
1639
9427
C08CA01
ATC
amlodipine; oral
1.2
14.5
3539
22040
L01AA04
ATC
NA
+∞
14.5
16
*
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
14.5
16
*
L57.0
ICD-10 Finland
Actinic keratosis
1.4
14.4
723
3687
N48.4
ICD-10 Finland
Impotence of organic origin
1.7
14.4
283
1155
R60.0
ICD-10 Finland
Localized oedema
1.4
14.1
799
4162
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.2
13.7
1753
10226
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
3.4
13.7
68
140
U28
ICPC
Limited function/disability (U)
2.5
13.6
108
301
SPAT1153
SPAT
Removal of sutures
1.2
13.6
2722
16631
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
13.6
15
*
A07DA03
ATC
loperamide; oral
1.6
13.5
323
1395
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
1.8
13.5
233
912
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
4.6
13.4
48
73
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
1.9
13.4
208
784
A06AH03
ATC
naloxegol; oral
2.5
13.4
110
313
N21.0
ICD-10 Finland
Calculus in bladder
2.2
13.4
137
435
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
6.9
13.4
35
36
1CD04
NOMESCO Finland
NA
112.9
13.3
16
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.3
13.3
1089
6007
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
13.3
1361
7732
U99
ICPC
Urinary disease other
3.2
13.1
73
162
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
1.7
13.0
278
1165
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
2.2
13.0
142
467
H84
ICPC
Presbyacusis
1.8
13.0
229
904
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1.6
13.0
386
1764
D63.0
ICD-10 Finland
Anaemia in neoplastic disease
14.8
13.0
23
11
WW200
SPAT
NA
0.7
13.0
375
3848
SPAT1312
SPAT
General health counselling
1.2
12.9
2253
13579
KGB00
NOMESCO Finland
Biopsy of penis
4.9
12.9
44
64
JN5AN
NOMESCO Finland
Total body isotope imaging
26.8
12.9
19
5
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
12.8
2327
18888
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
1.5
12.8
508
2478
M05BA02
ATC
clodronic acid; systemic
3.9
12.7
55
101
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
12.7
14
*
SPAT1301
SPAT
No procedures
1.2
12.7
2459
14966
U07
ICPC
Urine symptom/complaint other
1.6
12.5
344
1546
KGD05
NOMESCO Finland
Partial excision of body of penis
56.5
12.4
16
*
KA1FN
NOMESCO Finland
Isotope renography
3.1
12.4
72
167
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
6.0
12.3
35
41
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
12.2
461
2224
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
7.1
12.1
31
31
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.3
12.1
31
666
KA1AE
NOMESCO Finland
Kidney ultrasound examination
1.7
12.1
232
942
-44
ICPC
Preventive immunization/medic
1.4
12.1
535
2670
G04BD09
ATC
trospium; oral
2.2
12.0
130
426
-55
ICPC
Local injection/infiltration
3.1
12.0
69
159
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
4.5
11.9
43
67
JR1AS
NOMESCO Finland
Restricted PET-MRI of receptors/transporters in body
+∞
11.8
13
*
Y77
ICD-10 Finland
Ophthalmic devices associated with adverse incidents
+∞
11.8
13
*
WX704
NOMESCO Finland
Intubation
1.4
11.8
510
2533
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
0.4
11.6
55
913
KGH10
NOMESCO Finland
Operation for phimosis
1.6
11.6
323
1455
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
1.5
11.4
381
1795
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
1.9
11.4
160
586
Z51.88
ICD-10 Finland
Other specified medical care
2.0
11.3
147
522
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
3.3
11.3
58
124
R50.9
ICD-10 Finland
Fever, unspecified
1.3
11.3
1163
6609
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
2.0
11.2
142
497
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.3
11.2
703
3728
NF3AA
NOMESCO Finland
Femur X-ray examination
2.0
11.2
150
538
U50
ICPC
Urological, Medication/prescr/renewal
18.1
11.0
18
7
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
5.8
11.0
32
39
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
10.9
219
903
N06AX11
ATC
mirtazapine; oral
1.2
10.9
2273
13901
2AE02
NOMESCO Finland
NA
+∞
10.9
12
*
8041/3-C61.9
ICD-O-3
Small cell carcinoma, NOS, of prostate gland
+∞
10.9
12
*
N05AC02
ATC
thioridazine; oral
0.4
10.8
33
654
N04AA02
ATC
biperiden; systemic
0.4
10.8
40
733
N05AA02
ATC
levomepromazine; systemic
0.6
10.7
174
2006
N02AA01
ATC
morphine; systemic, rectal
2.0
10.7
147
534
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.4
10.7
490
2460
N41.0
ICD-10 Finland
Acute prostatitis
1.6
10.7
269
1182
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
6.6
10.6
28
30
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.6
10.5
277
1232
N05CF01
ATC
zopiclone; oral
1.2
10.4
2802
17499
N35.8
ICD-10 Finland
Other urethral stricture
3.3
10.4
54
117
N42.8
ICD-10 Finland
Other specified disorders of prostate
3.3
10.3
53
114
JN2BD
NOMESCO Finland
Extensive CT exmaniation of lower part of abdomen
4.5
10.3
37
58
H81
ICPC
Excessive ear wax
1.2
10.2
1366
7994
XKD11
NOMESCO Finland
NA
6.6
10.2
27
29
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
0.6
10.2
207
2270
TKE05
NOMESCO Finland
Aspiration cytology of prostate
14.1
10.1
18
9
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
5.8
10.1
29
35
R53
ICD-10 Finland
Malaise and fatigue
1.2
10.1
1407
8273
KH1AT
NOMESCO Finland
Urinary tract cathetrisation with ultrasound guidance
3.7
10.1
44
83
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.4
10.1
419
2067
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
0.6
10.0
121
1499
A10AA01
ATC
NA
0.5
10.0
58
893
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
+∞
10.0
11
*
WC225
NOMESCO Finland
Demanding therapy of local tumor recidive with hormone
+∞
10.0
11
*
H25.8
ICD-10 Finland
Other senile cataract
1.3
9.9
815
4496
P72
ICPC
Schizophrenia
0.3
9.9
23
515
G04AC01
ATC
NA
2.2
9.9
103
334
U02
ICPC
Urinary frequency/urgency
1.4
9.9
469
2375
ZX110
NOMESCO Finland
Intracutaneous
4.9
9.8
33
48
WX290
NOMESCO Finland
Other blockade of nerve
1.2
9.7
3006
18957
A10AA02
ATC
NA
0.6
9.7
122
1498
201
Kela drug reimbursment
Chronic cardiac insufficiency
0.7
9.7
386
3745
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
0.4
9.7
43
729
D64.8
ICD-10 Finland
Other specified anaemias
2.0
9.7
128
459
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1.8
9.6
170
677
KED76
NOMESCO Finland
TUVP
2.2
9.6
98
315
WX872
NOMESCO Finland
Intensive care
0.7
9.5
284
2893
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.2
9.5
1083
6226
M05BA08
ATC
zoledronic acid; parenteral
16.1
9.5
16
7
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.4
9.4
490
2524
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
9.4
2051
12580
JFA55
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in colon
3.3
9.3
48
104
SPAT1168
SPAT
Catheterisation training
2.6
9.3
67
181
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.3
9.3
793
4400
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
4.3
9.3
35
58
N30
ICD-10 Finland
Cystitis
1.7
9.2
184
758
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.1
9.2
105
353
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.4
9.2
453
2308
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
1.5
9.1
297
1391
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.3
9.1
962
5480
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.1
9.1
3067
19445
H02AB06
ATC
prednisolone; systemic
1.1
9.1
4121
26660
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
5.3
9.1
28
37
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.7
9.1
426
4033
XX7LT
NOMESCO Finland
Lutetium-177-PSMA treatment
+∞
9.1
10
*
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
1.6
9.1
238
1060
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.5
9.0
56
846
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.2
9.0
1459
8700
C60.2
ICD-10 Finland
Malignant neoplasm: Body of penis
42.3
9.0
12
*
L03AA02
ATC
filgrastim; parenteral
1.7
9.0
197
837
18599
ICD-8 Finland
Malignant neoplasm of prostate
77.6
8.9
11
*
ZX137
NOMESCO Finland
To penis
77.6
8.9
11
*
ZX120
NOMESCO Finland
Intravenous
1.3
8.9
715
3935
N05AH02
ATC
clozapine; systemic
0.3
8.9
22
475
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.9
8.9
1891
15212
KWA00
NOMESCO Finland
Repair of wound dehiscence in urological surgery
7.1
8.8
22
22
SPAT1154
SPAT
Insertion or removal of subcutaneous medicine capsule
5.3
8.8
27
36
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
0.5
8.7
87
1133
KGD00
NOMESCO Finland
Partial excision of glans penis
15.1
8.7
15
7
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.3
8.7
80
246
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
1.3
8.7
548
2909
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
0.7
8.7
388
3698
A10BK03
ATC
empagliflozin; oral
0.7
8.7
400
3797
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.2
8.7
1860
11382
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
0.5
8.7
78
1045
N05AF05
ATC
zuclopenthixol; systemic
0.3
8.6
13
363
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.2
8.6
963
5525
188
Kela drug reimbursment
Psychosis requiring demanding treatment
0.2
8.6
7
279
C03CA01
ATC
furosemide; systemic
1.1
8.5
3038
19324
P20
ICPC
Memory disturbance
1.3
8.5
835
4720
SPAT1310
SPAT
Counselling related to known health issue
1.2
8.5
2320
14478
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.2
8.4
83
263
H26.4
ICD-10 Finland
After-cataract
1.3
8.4
547
2923
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
3.4
8.4
41
86
T89
ICPC
Diabetes insulin dependent
0.6
8.4
111
1339
G04BXXX
ATC
NA
28.2
8.4
12
*
B01AE07
ATC
dabigatran etexilate; oral
1.5
8.3
322
1567
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.9
8.3
1927
15414
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
1.6
8.2
232
1055
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
8.2
2481
15592
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
8.2
9
*
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
8.2
9
*
KE1AK
NOMESCO Finland
Spectroscopy of prostate
+∞
8.2
9
*
KE029
NOMESCO Finland
Radiotherapy of local recidive of tumor of prostata and seminal vesicles
+∞
8.2
9
*
KDE12
NOMESCO Finland
Urethroscopic extraction of calculus of urethra
18.3
8.1
13
5
C60.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of penis
70.5
8.1
10
*
5703
FHL
Removal of lymph nodes from the retroperitoneal space
7.1
8.1
20
20
S50
ICPC
Skin, Medication/prescr/renewal
2.6
8.1
61
169
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
1.9
8.0
121
457
D29.2
ICD-10 Finland
Benign neoplasm: Testis
5.0
8.0
26
37
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
8.0
2044
12678
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
1.7
8.0
159
658
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.6
8.0
58
158
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
3.8
8.0
34
64
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.2
7.9
1011
5883
NF1AA
NOMESCO Finland
Hip X-ray examination
1.3
7.9
601
3285
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
1.4
7.9
319
1568
B01AB04
ATC
dalteparin; parenteral
1.4
7.9
337
1674
H02
ICPC
Hearing complaint
1.2
7.8
856
4899
N05AH03
ATC
olanzapine; systemic
0.7
7.8
177
1898
U01
ICPC
Dysuria/painful urination
1.6
7.8
180
778
C10AA01
ATC
simvastatin; oral
1.1
7.7
4659
30591
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.1
7.7
2484
15681
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
2.0
7.6
96
341
F29
ICD-10 Finland
Unspecified nonorganic psychosis
0.5
7.6
54
778
WX725
NOMESCO Finland
Noninvasive ventilation
1.4
7.6
333
1665
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.4
7.6
363
1844
L82
ICD-10 Finland
Seborrhoeic keratosis
1.2
7.6
999
5837
KED33
NOMESCO Finland
Transurethral incision of prostate
1.6
7.6
183
803
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.3
7.5
588
3224
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.4
7.5
396
2045
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
4.1
7.5
29
50
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
0.6
7.4
111
1301
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.1
7.4
2676
17009
R32
ICD-10 Finland
Unspecified urinary incontinence
1.9
7.4
110
414
N05AX12
ATC
aripiprazole; systemic
0.5
7.4
47
699
A04AD12
ATC
aprepitant; systemic
2.0
7.4
90
316
KC1AT
NOMESCO Finland
Puncture of urinary bladder with ultrasound guidance
3.8
7.4
31
58
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
1.9
7.3
108
407
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
5.7
7.3
21
26
DFF00
NOMESCO Finland
Pure tone audiometry
1.3
7.3
639
3560
N03AG01
ATC
valproic acid; systemic, rectal
0.7
7.3
206
2117
4194
NOMESCO Finland
NA
13.1
7.3
13
7
JR2PR
NOMESCO Finland
NA
+∞
7.2
8
*
YN2AS
NOMESCO Finland
NA
+∞
7.2
8
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
63.5
7.2
9
*
WC205
NOMESCO Finland
Simple therapy of local tumor recidive with hormone
63.5
7.2
9
*
F10.20
ICD-10 Finland
Alcohol dependence currently independent
0.5
7.2
72
933
K59.0
ICD-10 Finland
Constipation
1.4
7.2
371
1912
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.3
7.2
438
2319
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
7.2
845
4877
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
1.8
7.1
110
422
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.4
7.1
320
1609
TQX20
NOMESCO Finland
Implantation of subcutaneous medicament implant
4.1
7.1
27
46
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.3
7.1
524
2854
KH1AD
NOMESCO Finland
CT of urinary organs
1.4
7.1
289
1427
D16
ICPC
Rectal bleeding
1.8
7.1
122
485
N05AF03
ATC
chlorprothixene; systemic
0.5
7.0
73
938
D70.82
ICD-10 Finland
Drug-induced neutropenia
1.9
7.0
103
387
KCJ00
NOMESCO Finland
Cystostomy
5.6
7.0
20
25
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
1.4
6.9
281
1385
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
11.5
6.9
13
8
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
2.4
6.9
55
160
Z43.5
ICD-10 Finland
Attention to cystostomy
2.2
6.9
65
205
N05AA01
ATC
chlorpromazine; systemic, rectal
0.4
6.8
30
505
L04AA06
ATC
mycophenolic acid; systemic
0.5
6.7
43
637
TJF80
NOMESCO Finland
Ostomy education
2.0
6.7
82
287
SPAT1211
SPAT
Application of soft bandage
1.3
6.7
583
3247
ZX136
NOMESCO Finland
Intravesicalis
2.1
6.7
74
251
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.5
6.7
222
1050
SPAT1249
SPAT
Treatment-related counselling outside office
1.1
6.7
2895
18605
KCH42
NOMESCO Finland
Transurethral incision or resection of bladder neck
3.0
6.7
38
90
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
5.6
6.6
19
24
H02AB07
ATC
prednisone; oral
1.2
6.6
1093
6533
H13
ICPC
Plugged feeling ear
1.2
6.6
1409
8617
R42
ICD-10 Finland
Dizziness and giddiness
1.2
6.5
1496
9192
JGA35
NOMESCO Finland
Other endoscopic haemostatic procedure in rectum
12.1
6.5
12
7
XA800
NOMESCO Finland
Neuropsychological investigation
0.7
6.5
142
1526
PJA12
NOMESCO Finland
Sentinel node biopsy
1.7
6.5
120
488
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.5
6.4
235
1135
N13.8
ICD-10 Finland
Other obstructive and reflux uropathy
4.8
6.4
21
31
M01AX05
ATC
glucosamine; oral
1.2
6.4
1293
7864
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
2.1
6.4
71
240
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
0.3
6.4
14
319
R30.0
ICD-10 Finland
Dysuria
1.5
6.4
193
897
G04BD04
ATC
oxybutynin; oral, transdermal
1.4
6.4
309
1578
ZX001
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - SSD therapy
56.4
6.3
8
*
A04AA55
ATC
palonosetron, combinations; systemic
1.8
6.3
96
368
1860B
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOP MAL TEST (ABD/ING),CA EMBR/TERATOCA/CHORIOCA]
+∞
6.3
7
*
3031
Kela drug reimbursment
Apalutamidi
+∞
6.3
7
*
R33, C61
ICD-10 Finland
NA
+∞
6.3
7
*
C61, C795
ICD-10 Finland
NA
+∞
6.3
7
*
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
0.5
6.3
40
594
A10AE04
ATC
insulin glargine; parenteral
0.8
6.3
603
5218
G04BX08
ATC
NA
1.8
6.3
103
405
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.4
6.3
305
1560
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
4.0
6.2
24
42
-1
SPAT
NA
1.5
6.2
187
869
5BA08
NOMESCO Finland
NA
2.7
6.2
40
103
SPAT1260
SPAT
Consultation of another employee
1.2
6.2
1200
7274
R86.2
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of other drugs, medicaments and biological substances
12.9
6.2
11
6
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
0.4
6.2
18
361
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
6.2
47
134
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.2
6.1
772
4492
N32.0
ICD-10 Finland
Bladder-neck obstruction
1.7
6.1
112
457
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.5
6.1
229
1114
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.3
6.1
488
2691
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
0.5
6.1
63
807
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
0.7
6.1
251
2413
A04
ICPC
Weakness/tiredness general
1.2
6.1
703
4057
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
0.4
6.1
20
379
TKC50
NOMESCO Finland
Training of urinary bladder
3.8
6.0
25
47
A10BA02
ATC
metformin; oral
0.9
6.0
2447
18905
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
0.2
6.0
7
221
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
1.8
6.0
91
349
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
0.8
6.0
338
3113
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
8038
32092
2.00
307.65
4.1
3.5
152.7
122.1
e6/l
0.50
6839
25158
14927
71874
2.36
307.65
9.9
7.8
83.5
80.6
u/l
4.36
14381
67380
13744
58881
2.64
307.65
5.3
4.2
569.9
696.0
e6/l
0.15
283
1103
5956
22284
2.00
307.65
3.0
2.8
2.6
2.9
e6/l
1.36
5358
19512
5207
10338
4.00
307.65
2.2
2.1
7.7
14.8
nmol/l
307.65
4439
9070
7175
29212
1.89
307.65
3.9
3.4
0.4
0.5
e6/l
4.51
5987
22278
8401
35243
1.90
307.65
4.6
3.9
108.8
103.9
e6/l
0.12
7034
26548
12867
58978
2.13
307.65
8.0
3.9
15.5
23.9
%
307.65
8714
29228
15929
74214
2.99
307.65
11.9
3.9
10.5
2.4
ug/l
28.29
14018
66307
9949
41450
2.07
307.65
4.8
2.8
1.1
0.7
ug/l
47.66
7655
29065
10461
50693
1.67
242.91
7.7
6.6
11.7
13.5
umol/l
41.72
10042
48224
6795
29414
1.72
239.76
4.5
3.3
2.3
2.3
mmol/l
5.90
6028
25150
394
308
8.27
236.40
8.6
1.2
1533.4
78.9
u/l
0.49
132
43
9323
44447
1.64
222.97
4.5
4.4
—
—
—
0
0
4318
17105
1.77
201.01
3.9
3.2
0.6
0.8
e6/l
4.22
2804
9791
9675
48936
1.51
155.59
7.9
7.6
1.2
1.2
mmol/l
6.66
7981
41303
4338
18278
1.65
155.54
3.6
3.0
0.9
1.0
e6/l
0.47
2815
10886
754
1725
2.85
132.82
2.2
1.7
22.9
25.2
ug/l
0.38
740
1691
8842
44821
1.46
131.98
6.8
7.0
1.2
1.2
mmol/l
9.94
7982
40559
14996
85079
1.52
117.93
20.5
16.7
74.1
75.3
ml/min/173m2
11.07
13216
70824
15715
90127
1.55
116.76
19.2
17.9
30.7
29.7
mg/l
2.30
13281
74462
1788
6286
1.89
116.51
3.6
3.0
0.2
0.3
e6/l
2.60
1764
6204
16495
95710
1.61
115.98
22.7
21.4
139.5
139.6
mmol/l
4.27
16098
93284
16505
95915
1.61
112.97
22.9
21.5
4.0
4.0
mmol/l
3.35
16087
93379
9982
52711
1.41
111.77
9.4
9.1
4.4
4.5
e9/l
6.03
8748
45596
11212
60721
1.41
106.01
4.9
5.6
6.9
7.0
mmol/l
13.21
10671
57419
8524
44133
1.40
103.82
3.9
3.5
0.0
0.0
estimate
1.88
1947
7724
187
163
7.34
103.47
9.1
1.2
—
—
—
0
0
16454
96107
1.56
100.69
25.2
20.9
92.2
91.7
umol/l
0.79
16444
96058
8390
43508
1.39
99.84
5.0
4.6
0.0
0.0
estimate
0.50
2030
8308
8409
43799
1.39
96.18
3.8
3.5
0.0
0.0
estimate
0.33
1993
8038
8972
47374
1.38
93.39
11.3
11.5
1.3
1.4
inr
3.06
2661
12682
484
1066
2.93
90.93
2.7
3.9
7.2
9.5
nmol/l
0.51
476
1046
6666
33826
1.38
86.35
4.1
3.7
—
—
—
0
0
8332
43823
1.36
86.33
5.1
5.4
34.3
34.4
g/l
0.52
7687
40665
16674
98623
1.51
81.20
30.0
25.6
228.3
228.0
e9/l
0.19
16286
95405
16677
98678
1.51
80.53
30.0
25.6
6.9
7.1
e9/l
22.76
16236
95070
16675
98667
1.51
80.47
29.9
25.5
4.4
4.5
e12/l
154.36
16220
95009
16676
98680
1.51
80.35
30.1
25.7
133.5
137.9
g/l
192.90
16428
96767
16250
95706
1.47
79.41
12.5
11.2
26.1
28.3
u/l
18.84
15598
91730
4981
24729
1.37
70.35
4.2
3.9
0.0
0.0
estimate
0.02
1837
7468
4868
24110
1.38
69.64
2.7
2.6
—
—
—
0
0
3616
17063
1.42
68.44
3.7
3.3
2.5
2.4
mmol/l
4.30
3180
14769
5173
26434
1.33
58.30
2.2
2.3
3.0
3.0
mg/l
0.29
4337
22377
3080
14549
1.41
56.67
4.7
4.2
250.9
244.1
u/l
1.06
2917
13754
1863
7986
1.53
56.25
4.7
4.3
1.2
1.2
mmol/l
1.03
1635
7020
526
1561
2.17
53.68
6.1
2.7
598.0
1077.9
u/ml
0.37
512
1534
2408
11055
1.44
51.45
3.8
3.8
—
—
—
0
0
7382
40701
1.24
41.93
12.1
10.8
0.0
0.0
e9/l
0.01
6136
33362
6387
34776
1.25
40.08
2.8
3.0
240.9
195.4
ug/l
9.41
5657
31677
4662
24591
1.27
38.02
1.6
1.6
18.5
18.9
nmol/l
1.38
3951
21194
13257
78204
1.24
38.02
21.6
18.9
38.4
39.8
%
31.93
8029
49867
12285
72034
1.22
36.26
25.3
21.3
13.9
13.9
%
0.49
12087
70289
7988
44879
1.22
36.11
5.5
6.4
23.9
25.4
%
23.87
7350
41565
11405
66467
1.22
35.18
3.9
4.1
14.9
13.2
mm/h
16.63
10274
60948
7765
43857
1.21
31.84
5.4
6.2
2.9
2.9
%
0.02
7183
40786
14725
88453
1.23
31.24
5.1
5.1
6.1
6.2
mmol/l
12.40
12880
79682
7793
44138
1.20
30.60
5.3
6.1
60.2
59.0
%
13.35
7220
41101
213
585
2.33
26.27
2.8
1.3
14.8
11.6
iu/l
1.87
179
457
7322
41798
1.18
24.39
4.2
4.2
57.2
83.5
ng/l
2.44
6003
33077
4683
25734
1.20
23.90
4.3
4.5
83.4
80.6
%
10.91
4601
25193
7385
42297
1.17
23.29
2.1
2.1
92.2
90.7
pmol/l
1.95
4230
24614
2401
12373
1.26
22.32
4.7
4.9
31.7
31.7
%
0.00
1551
8539
6181
34998
1.18
22.07
3.1
3.3
2005.3
1832.7
ng/l
1.37
5330
30684
3527
19001
1.22
21.78
1.9
1.9
—
—
—
0
0
12963
77820
1.17
21.75
3.8
3.9
2.2
2.2
mu/l
0.21
11207
69406
14205
85967
1.18
21.31
6.5
6.9
40.7
41.4
mmol/mol
14.48
12715
78783
14929
90740
1.19
21.27
5.3
5.4
2.5
2.5
mmol/l
4.08
13206
82838
2201
11291
1.27
21.18
3.8
4.3
20.0
32.0
ug/l
1.55
1824
9610
3932
21469
1.20
21.04
1.9
1.8
1129.3
1134.2
nmol/l
0.12
2875
16311
14557
88540
1.17
18.90
4.8
4.9
4.3
4.2
mmol/l
14.57
12944
81286
14419
87720
1.17
18.13
4.7
4.8
1.3
1.3
mmol/l
37.48
12721
79843
2742
14653
1.22
18.01
2.5
2.5
1.7
1.7
%
0.23
2383
12902
335
1248
1.72
17.78
1.4
1.2
—
—
—
0
0
3288
17901
1.20
17.77
2.6
2.8
12.2
12.6
umol/l
2.25
3011
16604
8178
47876
1.15
17.43
5.2
6.0
1.7
1.9
e9/l
16.52
7016
41621
8233
48314
1.14
16.66
5.3
6.1
0.2
0.2
e9/l
4.19
7046
41910
2880
15603
1.20
16.27
6.8
7.7
104.9
104.6
mmol/l
2.48
2822
15214
3082
16802
1.20
16.27
2.6
2.8
2.2
2.2
g/l
5.00
2815
15567
3586
19814
1.18
16.23
4.3
3.9
1.0
1.0
kg/l
0.53
593
2953
242
844
1.83
16.08
1.4
1.2
105.2
57.1
u/l
1.62
178
528
13994
85196
1.15
15.97
4.2
4.4
1.3
1.3
mmol/l
7.92
12218
77058
2094
11085
1.22
14.92
2.7
2.6
66.1
67.6
e9/l
1.33
1620
8573
2904
15916
1.19
14.26
2.7
2.8
22.7
22.9
%
0.28
2422
13538
3229
17870
1.18
14.12
3.2
3.6
0.8
0.8
mmol/l
0.14
3034
16680
993
4854
1.31
13.76
2.0
2.0
—
—
—
0
0
5437
31403
1.14
13.09
2.5
2.7
58.7
60.6
u/l
0.87
4988
29121
913
4462
1.31
12.68
1.9
1.8
—
—
—
0
0
1329
10342
0.80
12.49
1.7
1.8
1.7
1.7
%
0.11
1096
8715
3852
21847
1.15
11.97
1.9
1.7
23006641.8
28327590.9
pmol/l
0.28
3047
17898
1562
8204
1.23
11.94
3.1
4.2
0.1
0.1
%
0.32
520
2640
1359
7051
1.24
11.65
1.8
1.7
—
—
—
0
0
1350
7008
1.24
11.52
7.9
10.7
—
—
—
0
0
5448
31674
1.13
11.50
2.0
2.1
79.0
75.9
nmol/l
11.81
4641
27794
147
489
1.92
11.44
1.9
1.5
6.9
6.5
u/l
0.12
78
227
5153
29902
1.13
11.15
3.6
3.3
35.6
37.8
u/l
0.95
4850
28158
1479
7815
1.22
10.65
3.1
4.0
1.1
0.6
%
4.35
389
2050
564
2653
1.36
10.21
2.4
2.7
15.7
16.4
%
3.25
317
1450
1081
5576
1.24
9.79
2.0
2.0
3.1
2.1
ug/l
0.95
930
4944
126
427
1.88
9.37
1.2
1.1
22.2
34.3
u/l
1.33
76
329
126
427
1.88
9.37
1.2
1.1
77.1
102.7
u/l
1.98
81
346
1478
7908
1.20
9.36
3.4
3.9
1.6
1.6
mmol/l
0.09
1050
5771
583
2796
1.33
9.33
4.1
4.8
2.4
2.5
mmol/l
0.24
371
1871
583
2797
1.33
9.31
4.1
4.8
4.9
5.0
kpa
0.53
568
2725
1541
8288
1.20
9.22
3.5
3.9
5.1
5.1
kpa
1.24
1411
7652
1420
7595
1.20
9.03
1.6
1.7
—
—
—
0
0
14
374
0.24
7.87
12.0
12.6
1032.4
803.9
nmol/l
0.72
14
351
129
468
1.76
7.80
1.6
1.2
107.6
110.3
u/l
0.07
116
399
9355
56718
1.09
7.73
3.2
3.3
58.7
63.1
u/l
3.13
8465
52082
297
1318
1.44
7.67
2.0
2.2
30.4
28.0
mg/l
0.23
79
360
124
449
1.76
7.57
1.7
1.2
38.7
28.9
u/l
0.75
110
381
204
843
1.54
7.47
1.8
1.9
2.1
1.7
u/field
0.39
90
341
28
495
0.36
7.30
1.2
1.3
—
—
—
0
0
389
3285
0.75
7.14
1.4
1.6
—
—
—
0
0
1523
8373
1.17
7.05
3.3
3.0
62.3
61.4
ml/min/173m2
0.37
624
3450
148
579
1.63
6.86
1.7
1.8
2.3
2.9
u/field
0.44
97
411
357
3031
0.74
6.82
1.4
1.5
—
—
—
0
0
105
1131
0.59
6.75
1.4
1.2
1.5
1.4
nmol/l
0.62
95
1022
589
2966
1.27
6.68
2.7
3.0
7.8
7.8
kpa
0.25
550
2741
25
46
3.45
6.56
1.0
1.3
—
—
—
0
0
417
2012
1.32
6.54
2.8
3.8
2.1
1.5
%
2.15
299
1557
1144
6184
1.19
6.51
1.6
1.7
1.6
1.5
g/l
2.66
968
5261
41
576
0.45
6.23
5.3
5.8
37.6
1466.9
u/ml
—
7
118
961
5137
1.20
6.22
4.5
5.6
0.9
0.9
%
0.39
887
4835
398
1924
1.32
6.19
1.8
2.0
1.9
1.8
mmol/l
1.12
389
1873
2305
13199
1.12
5.87
1.8
1.8
—
—
—
0
0
316
2661
0.75
5.77
1.6
1.6
18.9
7.5
iu/ml
0.32
77
639
933
5020
1.19
5.65
3.8
4.3
24.6
24.6
mmol/l
0.34
849
4614
552
2818
1.25
5.64
2.2
2.3
124.9
131.0
g/l
5.64
417
2055
654
5027
0.82
5.54
1.9
1.9
—
—
—
0
0
2665
15436
1.11
5.53
5.8
6.7
1.0
1.0
mmol/l
0.63
2468
14425
526
4130
0.80
5.48
1.8
1.7
43.0
44.6
nmol/l
0.86
512
3950
131
528
1.58
5.48
3.2
2.9
206.9
210.6
u/l
0.19
131
521
967
5248
1.18
5.31
4.5
5.5
1.6
1.7
%
2.26
892
4944
9707
59518
1.07
5.02
3.0
3.1
15.0
15.0
pmol/l
1.69
8374
52674
3155
18534
1.10
4.90
1.9
2.1
30.4
30.4
s
0.12
3062
18006
164
1486
0.70
4.84
3.3
4.5
314.5
342.1
umol/l
1.97
125
1249
2283
13220
1.11
4.75
1.9
1.8
—
—
—
0
0
285
2362
0.76
4.72
1.3
1.4
1.0
0.8
nmol/l
2.01
238
1952
1967
11306
1.12
4.70
2.8
3.0
9.3
11.4
umol/l
3.23
1741
10106
305
2499
0.77
4.63
1.7
1.7
11.0
11.9
mg/l
0.92
274
2338
539
2812
1.22
4.59
5.7
7.6
104.9
105.2
mmol/l
0.64
473
2556
651
3463
1.20
4.54
2.9
3.3
24.3
24.5
mmol/l
0.31
580
3038
445
2277
1.25
4.54
3.5
3.5
34.6
31.2
mg/l
0.94
289
1511
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
896
4905
1.17
4.48
2.8
2.9
0.3
0.3
u/ml
0.42
513
2794
1830
10513
1.12
4.42
2.8
3.2
259.5
266.6
ng/l
0.19
1671
9670
1652
11627
0.89
4.39
2.3
2.5
6.9
8.4
ug/l
2.63
1396
10279
2958
17443
1.09
4.20
29.6
29.8
1.5
1.5
inr
0.13
455
2307
3987
23806
1.08
4.18
1.7
1.7
1.3
1.4
mmol/l
2.60
3134
19578
2331
13617
1.10
4.07
6.8
8.1
95.5
95.2
%
1.24
2210
13141
153
1354
0.72
4.01
2.5
2.4
—
0.7
—
0
12
2098
12216
1.10
3.92
7.2
8.7
120.8
122.8
g/l
4.26
2008
11815
256
1248
1.31
3.92
2.7
3.7
61.5
59.5
%
0.54
148
806
1243
7033
1.13
3.92
8.2
9.7
23.8
24.2
mmol/l
4.55
1169
6486
263
2143
0.78
3.89
1.5
1.7
3.4
4.5
mg/l
0.82
196
1521
1899
11008
1.11
3.89
6.5
7.5
1.4
1.4
mmol/l
1.30
1815
10550
287
2311
0.79
3.86
1.3
1.3
—
—
—
0
0
7037
42943
1.06
3.86
2.2
2.2
—
—
—
0
0
1216
6879
1.13
3.85
1.5
1.5
—
—
—
0
0
52
572
0.58
3.83
2.1
2.3
—
—
—
0
0
172
1481
0.74
3.81
1.6
1.7
1.0
1.0
g/l
0.12
133
1118
531
3993
0.84
3.68
4.5
4.8
4.0
4.0
mmol/l
0.09
480
3743
208
1727
0.76
3.60
1.4
1.5
114.8
115.3
u/ml
0.02
48
386
320
1625
1.25
3.58
2.6
2.6
4.1
4.1
mmol/l
0.54
314
1612
320
1625
1.25
3.58
2.6
2.6
105.9
105.7
mmol/l
0.17
314
1611
354
2755
0.81
3.54
1.6
1.6
19154.5
15993.0
e6/l
0.51
236
2027
2525
14913
1.09
3.46
6.6
7.8
0.6
1.0
mmol/l
5.61
1928
11652
3208
19135
1.08
3.42
1.6
1.8
1.8
1.5
mg/l
1.97
2521
15117
471
3552
0.84
3.40
2.3
2.4
120.6
137.1
ug/min
0.30
254
2156
107
972
0.70
3.34
1.1
1.1
3.1
1.8
iu/ml
—
8
46
245
1217
1.28
3.32
1.4
1.5
—
—
—
0
0
19
275
0.44
3.32
2.1
2.7
126.4
135.8
nmol/l
0.23
19
239
638
4679
0.86
3.27
4.1
4.5
1.4
1.4
mmol/l
0.73
621
4588
427
2262
1.20
3.24
2.2
1.3
7.9
7.1
u/l
1.09
343
1823
527
3909
0.85
3.15
1.6
1.7
37.7
37.5
u/l
0.07
437
3339
92
394
1.48
3.11
2.1
2.5
—
—
—
0
0
92
394
1.48
3.11
2.1
2.5
—
—
—
0
0
72
692
0.66
3.06
2.0
2.2
—
—
—
0
0
48
504
0.60
3.03
1.0
1.1
0.7
2.8
u/ml
2.80
16
206
240
1205
1.27
3.02
1.4
1.5
—
—
—
0
0
240
1205
1.27
3.02
1.4
1.5
—
—
—
0
0
1751
10242
1.09
3.01
2.6
2.6
65.7
66.3
g/l
2.77
1554
9378
54
550
0.62
3.00
24.0
30.6
113.7
114.2
ug/l
0.02
46
470
36
406
0.56
2.99
1.0
1.0
0.3
0.3
u/ml
0.09
12
107
27
330
0.52
2.95
1.1
1.1
—
—
—
0
0
733
4091
1.14
2.94
3.2
3.6
1167.3
2095.8
u/ml
0.58
621
3593
61
599
0.65
2.89
1.0
1.1
1.0
1.5
u/ml
0.36
15
139
44
466
0.60
2.89
1.0
1.0
0.6
2.6
u/ml
2.38
15
180
247
1252
1.26
2.89
1.4
1.5
—
—
—
0
0
588
3236
1.16
2.88
1.3
1.3
—
—
—
0
0
396
2980
0.84
2.85
1.9
2.6
29.6
34.4
umol/l
5.21
319
2487
238
1204
1.26
2.84
1.4
1.5
—
—
—
0
0
198
1598
0.78
2.83
1.1
1.1
62.2
189.5
iu/ml
0.58
39
310
88
799
0.70
2.81
1.1
1.2
78.4
148.7
titre
1.73
19
135
1257
7265
1.11
2.80
6.0
7.8
24.4
24.6
mmol/l
0.96
1243
7191
323
2469
0.83
2.78
1.4
1.4
1.2
1.2
g/l
0.12
308
2343
488
2657
1.17
2.76
3.7
3.7
7.4
7.9
mmol/l
4.33
478
2607
336
2557
0.83
2.76
1.2
1.2
0.2
0.6
u/ml
2.31
28
243
240
1223
1.25
2.71
1.4
1.5
—
—
—
0
0
37
401
0.59
2.69
1.3
1.3
69.2
62.3
%
0.70
32
346
510
2796
1.16
2.66
3.7
3.5
1.6
1.7
mmol/l
0.58
500
2736
313
2387
0.83
2.65
1.3
1.4
0.2
0.2
g/l
0.77
295
2258
567
4113
0.87
2.58
1.3
1.3
480.2
320.3
u/ml
0.83
522
3806
307
2338
0.83
2.57
1.2
1.2
122.8
115.0
titre
0.06
29
204
103
893
0.73
2.53
1.1
1.1
—
—
—
0
0
2498
14937
1.07
2.50
6.7
7.8
12.0
11.8
kpa
2.08
2351
14230
90
795
0.72
2.49
1.1
1.1
0.4
1.6
u/ml
3.29
36
333
2499
14948
1.07
2.47
6.7
7.8
5.1
5.1
kpa
0.25
2347
14252
250
1932
0.82
2.46
1.3
1.4
36.7
28.7
e6/l
0.11
181
1523
105
485
1.38
2.45
1.8
2.2
—
—
—
0
0
80
717
0.71
2.42
1.1
1.2
—
—
—
0
0
129
617
1.33
2.41
1.6
2.0
—
—
—
0
0
251
1934
0.82
2.40
1.3
1.4
478.3
2648.4
e6/l
1.23
194
1602
129
620
1.32
2.35
1.6
2.0
—
—
—
0
0
129
620
1.32
2.35
1.6
2.0
—
—
—
0
0
129
620
1.32
2.35
1.6
2.0
—
—
—
0
0
149
733
1.29
2.30
1.4
1.4
—
—
—
0
0
198
1009
1.25
2.30
1.5
1.5
—
—
—
0
0
200
1567
0.81
2.28
1.2
1.2
277.8
288.7
u/ml
0.24
126
992
700
4966
0.89
2.27
1.5
1.5
16.6
16.5
u/ml
0.01
13
125
142
1157
0.78
2.27
1.4
1.3
128519.7
145921.7
e6/l
0.14
101
809
146
718
1.29
2.26
1.4
1.4
—
—
—
0
0
1000
5783
1.10
2.26
4.1
4.4
23.7
23.9
mmol/l
1.12
898
5157
36
373
0.61
2.25
3.2
2.8
26.4
29.7
umol/l
1.85
30
284
37
139
1.69
2.24
1.0
1.1
2.3
2.8
umol/l
0.69
32
127
103
483
1.36
2.22
1.8
2.2
—
—
—
0
0
103
484
1.35
2.20
1.8
2.2
—
—
—
0
0
206
1600
0.82
2.17
1.0
1.1
4.6
9.4
u/ml
0.76
15
138
67
601
0.71
2.09
1.1
1.2
—
—
—
0
0
120
986
0.77
2.08
1.2
1.2
216.7
168.0
miu/ml
0.47
26
221
5740
37600
0.96
2.07
4.0
4.2
9.5
10.6
mg/mmol
0.91
3700
25936
32
119
1.71
2.03
1.0
1.1
10.5
19.2
iu/ml
0.67
12
45
514
2886
1.13
2.00
1.5
1.7
—
—
—
0
0
539
3848
0.89
1.99
1.6
1.6
91.5
250.7
titre
4.02
23
156
144
722
1.27
1.97
1.4
1.5
—
—
—
0
0
347
1902
1.16
1.92
1.3
1.3
—
—
—
0
0
76
656
0.73
1.90
2.1
2.0
—
—
—
0
0
5496
35975
0.96
1.89
3.1
3.4
8.1
8.4
mmol/l
3.65
4337
29945
2078
13944
0.94
1.89
1.2
1.2
1.8
2.1
u/ml
0.45
506
3514
104
503
1.31
1.88
1.5
1.5
2.6
4.5
%
1.30
23
121
272
1466
1.18
1.86
6.3
12.6
7.3
7.5
mmol/l
0.83
227
1193
7
108
0.41
1.85
2.0
3.9
—
—
—
0
0
62
277
1.42
1.83
1.4
1.7
4.5
6.0
nmol/l
0.28
56
246
16
194
0.52
1.82
2.7
2.9
5.8
7.0
mg/l
0.62
11
156
5289
32556
1.04
1.82
2.2
2.3
235.1
260.5
u/l
1.22
4945
30533
143
725
1.25
1.81
1.4
1.5
—
—
—
0
0
386
2145
1.15
1.79
1.5
1.8
—
—
—
0
0
90
430
1.33
1.79
5.5
5.8
36.1
70.3
u/ml
0.61
30
129
9
125
0.46
1.79
1.0
1.0
—
—
—
0
0
493
2786
1.13
1.77
1.5
1.7
—
—
—
0
0
33
130
1.61
1.74
2.8
2.7
0.2
0.2
u/field
0.10
33
130
256
1383
1.18
1.73
1.4
1.7
—
—
—
0
0
5439
35548
0.96
1.72
3.2
3.5
341.8
350.7
mg/l
0.06
3556
24889
453
2555
1.13
1.69
1.4
1.4
—
—
—
0
0
453
2556
1.13
1.68
1.4
1.4
—
—
—
0
0
1483
8845
1.07
1.67
2.4
2.6
34.1
58.5
u/l
1.68
1241
7620
78
655
0.76
1.66
1.2
1.2
1.3
1.2
nmol/l
0.09
63
488
166
1276
0.82
1.66
1.1
1.1
—
—
—
0
0
43
183
1.49
1.65
1.6
1.7
80.7
111.2
ug/l
1.42
34
150
55
486
0.72
1.64
1.5
2.2
968.7
4847.2
e6/l
1.12
42
352
232
1251
1.18
1.62
2.4
3.0
—
—
—
0
0
1938
11669
1.06
1.62
4.1
4.2
1.6
1.7
mmol/l
0.77
1539
9396
38
158
1.53
1.62
1.5
1.2
68.7
129.1
u/ml
0.76
33
149
1670
10012
1.06
1.61
2.1
2.4
0.2
0.2
g/l
0.45
1528
9206
520
2969
1.12
1.60
1.4
1.6
—
—
—
0
0
225
1676
0.85
1.59
1.2
1.2
—
—
—
0
0
15
176
0.54
1.57
2.0
2.4
—
175.8
—
0
26
727
4227
1.10
1.57
2.8
3.4
68.4
45.5
mg/l
0.62
564
3441
2004
13377
0.95
1.56
1.5
1.5
2.7
3.0
g/l
4.68
1182
8206
48
429
0.71
1.55
1.4
2.1
31818.8
7603.0
e6/l
0.82
32
249
162
850
1.21
1.54
1.4
1.5
—
—
—
0
0
708
4116
1.10
1.54
2.8
3.4
3.4
5.6
ratio
0.58
59
316
178
1346
0.84
1.52
1.1
1.1
1.5
1.6
g/l
0.47
158
1225
1935
11683
1.06
1.49
4.1
4.1
5.8
5.8
kpa
1.28
1890
11308
44
396
0.70
1.49
1.1
1.0
—
—
—
0
0
313
2260
0.88
1.47
1.5
1.6
—
—
—
0
0
14
45
1.98
1.42
1.4
1.5
79.0
133.7
ug/l
—
7
31
5
79
0.40
1.42
1.4
1.1
—
—
—
0
0
1030
6996
0.93
1.41
2.5
2.7
10.7
11.0
g/l
0.79
915
6423
724
4235
1.09
1.40
2.8
3.4
73.3
63.9
mg/l
0.44
557
3445
41
368
0.71
1.39
1.3
1.5
12.8
13.3
g/l
0.17
30
280
425
2999
0.90
1.38
1.9
1.9
176.4
199.1
pmol/l
3.50
390
2783
105
826
0.81
1.37
1.0
1.0
317.1
312.4
ng/l
0.05
78
562
106
828
0.81
1.31
1.0
1.0
717.0
716.0
ng/l
0.01
75
547
106
828
0.81
1.31
1.0
1.0
38.8
41.3
ng/l
0.29
78
551
209
1534
0.86
1.29
1.7
1.8
268.6
272.1
mu/l
0.08
200
1434
162
1212
0.85
1.27
1.9
2.3
740.0
698.1
ml
0.53
91
793
1164
6963
1.07
1.26
4.0
4.7
108.3
109.6
ng/l
0.14
976
6066
64
526
0.77
1.24
1.5
1.4
8.0
6.6
u/l
0.23
53
447
124
946
0.83
1.23
1.4
1.4
—
—
—
0
0
28
262
0.68
1.22
1.4
1.3
—
—
—
0
0
18
67
1.71
1.22
1.1
1.1
1.2
1.0
u/field
0.35
13
43
6
82
0.46
1.20
1.0
1.0
—
—
—
0
0
313
2225
0.89
1.20
1.2
1.3
604.0
607.7
mg/l
0.04
291
2115
35
313
0.71
1.20
1.5
1.2
1.7
1.4
mmol/l
1.19
22
202
357
2037
1.11
1.19
1.4
1.4
—
—
—
0
0
272
1947
0.89
1.18
1.2
1.3
3.8
4.0
mmol/l
1.81
252
1826
20
78
1.63
1.16
1.1
1.4
—
—
—
0
0
12
135
0.56
1.15
1.1
1.1
—
—
—
0
0
1754
11641
0.95
1.15
1.2
1.2
33.6
41.8
iu/ml
1.41
477
3450
2018
12302
1.05
1.12
6.5
7.6
11.8
11.2
mmol/l
2.02
1894
11616
387
2706
0.91
1.11
1.1
1.1
159.1
208.1
titre
0.37
11
69
106
556
1.21
1.10
1.5
1.5
—
—
—
0
0
106
556
1.21
1.10
1.5
1.5
—
—
—
0
0
683
4035
1.08
1.10
2.4
2.6
1.3
1.1
g/l
0.52
560
3439
1608
10680
0.95
1.10
1.2
1.2
10.8
15.0
u/ml
1.32
500
3798
136
732
1.18
1.07
3.6
3.5
—
—
—
0
0
40
342
0.74
1.06
1.6
1.9
15.4
594.6
ug/l
1.16
40
322
3512
21680
1.03
1.04
4.0
4.2
643.6
707.0
ng/l
0.10
3058
18950
5
70
0.45
1.04
1.4
1.3
—
—
—
0
0
30
267
0.71
1.03
2.5
2.8
14.0
26.1
mu/l
2.80
24
247
70
354
1.26
1.03
1.8
1.7
-0.1
0.1
mmol/l
0.18
65
332
633
3742
1.08
1.02
1.8
1.8
—
—
—
0
0
21
199
0.67
1.01
2.6
5.0
46.8
60.5
u/l
—
5
72
140
1034
0.86
1.00
1.5
2.0
760.0
3085.3
titre
—
8
53
50
243
1.31
1.00
2.2
2.7
6.8
8.4
mmol/l
2.51
36
147
22
92
1.52
0.99
3.1
1.5
—
—
—
0
0
128
693
1.17
0.97
1.3
1.2
2.3
2.2
mmol/l
0.43
118
648
116
623
1.18
0.97
2.8
3.7
—
—
—
0
0
109
818
0.85
0.96
1.1
1.2
90.9
95.8
%
1.11
96
758
79
610
0.82
0.95
1.6
1.6
0.9
0.9
g/l
0.02
79
604
194
1087
1.13
0.93
1.4
1.3
0.2
0.3
nmol/l
0.60
21
108
797
4768
1.06
0.93
2.1
2.4
—
—
—
0
0
16
157
0.65
0.93
1.1
1.1
—
—
—
0
0
744
4442
1.07
0.93
2.1
2.4
10.2
10.5
g/l
1.09
592
3755
1173
7812
0.95
0.93
1.2
1.3
—
—
—
0
0
797
4771
1.06
0.92
2.1
2.4
7.4
7.3
g/l
0.84
558
3542
9
100
0.57
0.91
1.8
1.7
—
—
—
0
0
794
4756
1.06
0.90
2.1
2.4
4.0
3.9
g/l
0.67
539
3410
11
117
0.60
0.90
1.0
1.0
—
—
—
0
0
193
1085
1.13
0.89
1.4
1.3
0.7
1.8
nmol/l
0.59
185
1041
17
163
0.66
0.89
5.6
5.0
—
—
—
0
0
115
852
0.86
0.89
1.1
1.2
—
—
—
0
0
13
49
1.68
0.88
1.2
1.4
1.4
0.9
u/field
—
7
24
15
59
1.61
0.88
1.2
1.2
—
—
—
0
0
250
1759
0.90
0.87
2.0
2.8
639.2
6268.9
u/ml
0.72
17
128
485
2860
1.08
0.87
1.8
2.2
90.0
84.4
%
7.45
460
2723
141
1027
0.87
0.87
1.1
1.1
108.9
109.2
%
0.05
119
930
6
73
0.52
0.86
9.0
5.5
—
—
—
0
0
164
916
1.14
0.85
1.4
1.3
—
—
—
0
0
463
3163
0.93
0.85
1.3
1.4
7.8
11.2
iu/ml
—
7
62
153
1105
0.88
0.84
1.4
1.3
52.2
101.5
pmol/l
1.05
86
331
306
2126
0.91
0.84
1.6
1.7
—
—
—
0
0
0
16
0.00
0.82
0.0
1.8
—
22.7
—
0
6
0
17
0.00
0.81
0.0
6.0
—
0.4
—
0
17
227
1298
1.11
0.81
3.2
3.5
—
—
—
0
0
6
20
1.90
0.81
1.0
1.2
2.2
3.1
%
—
6
20
17
71
1.52
0.80
1.3
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
35
288
0.77
0.77
1.6
1.8
201.6
188.9
%
0.36
30
268
333
2293
0.92
0.77
3.9
6.0
3594.3
1300.4
iu/ml
0.31
44
384
116
640
1.15
0.75
1.3
1.3
95.6
70.8
titre
—
9
52
317
2184
0.92
0.75
1.5
1.6
—
—
—
0
0
30
143
1.33
0.73
2.1
2.1
—
—
—
0
0
17
155
0.70
0.72
1.1
1.4
75.5
71.2
%
1.23
17
145
17
155
0.70
0.72
1.1
1.4
326.6
1747.3
mu/l
1.17
17
145
36
291
0.79
0.71
1.0
1.1
—
6.9
u/ml
—
0
22
30
144
1.32
0.70
2.2
2.1
—
—
—
0
0
435
2582
1.07
0.70
2.0
2.5
208.1
206.8
%
0.10
410
2456
245
1421
1.10
0.70
1.6
1.5
64.7
63.5
%
0.18
151
948
20
90
1.41
0.68
1.1
1.0
—
—
—
0
0
98
716
0.87
0.68
2.1
2.3
64.4
146.0
ug/min
1.34
31
173
12
48
1.59
0.68
2.8
3.2
178.3
26.8
pmol/l
—
7
30
1345
8237
1.04
0.68
8.5
9.8
0.6
0.7
%
9.56
1332
8176
607
3649
1.06
0.67
2.2
2.4
36.6
37.2
g/l
1.56
499
3158
441
2983
0.94
0.66
1.1
1.1
107.4
97.5
iu/ml
0.23
136
927
694
4632
0.95
0.66
2.4
2.4
607.8
627.2
ug/l
0.06
672
4423
38
302
0.80
0.66
2.6
2.7
—
—
—
0
0
291
1707
1.08
0.66
1.4
1.6
—
—
—
0
0
135
962
0.89
0.65
1.5
1.8
4.1
4.4
mg/l
0.51
123
916
143
810
1.12
0.65
1.6
1.6
31.1
28.7
u/ml
0.19
31
185
360
2134
1.07
0.63
2.3
1.2
42.2
38.8
u/l
0.18
307
1849
1201
7355
1.04
0.62
2.4
2.6
368.5
372.5
nmol/l
0.24
1117
6795
98
710
0.88
0.62
1.1
1.2
11.0
12.3
mmol/l
0.93
27
276
29
236
0.78
0.62
1.3
1.3
0.3
0.3
g/l
0.52
20
188
9
91
0.63
0.62
1.0
1.0
—
—
—
0
0
92
668
0.87
0.61
1.0
1.1
283.6
277.4
mg/l
0.44
84
608
481
3233
0.94
0.61
1.4
1.4
—
—
—
0
0
107
769
0.88
0.61
1.0
1.1
—
—
—
0
0
113
809
0.89
0.60
1.1
1.1
52.5
56.9
au/ml
—
5
15
26
126
1.31
0.59
1.1
1.1
—
—
—
0
0
731
4435
1.05
0.59
2.2
2.4
3.2
3.0
g/l
2.43
546
3479
53
401
0.84
0.59
7.8
8.3
—
—
—
0
0
13
119
0.69
0.59
1.6
1.3
0.6
1.0
ml/s/173m2
—
8
77
58
435
0.85
0.59
2.4
2.3
53.3
57.0
umol/l
0.52
44
361
423
2530
1.06
0.58
2.7
3.4
232.1
1113.3
u/ml
2.54
376
2316
6
22
1.73
0.58
2.2
1.1
988.2
480.1
nmol/l
—
6
22
124
880
0.89
0.58
1.1
1.1
—
—
—
0
0
19
162
0.74
0.58
1.4
2.4
—
—
—
0
0
16
140
0.73
0.57
1.1
1.2
393755.2
155842.8
nmol/l
0.24
16
120
129
910
0.90
0.55
1.2
1.4
1.2
1.4
promille
0.47
112
694
12
51
1.49
0.55
1.1
1.1
3.3
2.7
u/l
—
5
7
95
682
0.88
0.55
1.0
1.1
2.2
4.3
u/ml
1.66
29
235
23
189
0.77
0.55
1.7
1.2
70.6
77.6
%
0.24
11
122
86
479
1.14
0.54
1.7
2.2
—
—
—
0
0
117
828
0.90
0.54
1.1
1.1
5.5
8.0
au/ml
—
10
35
25
123
1.29
0.53
1.6
1.7
41.6
45.9
umol/l
0.46
25
123
100
713
0.89
0.52
1.1
1.1
—
—
—
0
0
18
152
0.75
0.52
1.3
1.3
96.4
80.3
%
—
7
74
1341
8264
1.03
0.52
8.3
9.6
1.2
1.4
%
5.40
1329
8198
28
222
0.80
0.51
1.4
1.3
121.8
110.7
%
0.74
21
201
419
2807
0.95
0.51
1.4
1.5
257.2
247.1
ug/g
0.44
260
1733
117
668
1.11
0.51
1.3
1.3
114.3
433.4
titre
—
7
76
67
489
0.87
0.51
1.1
1.1
—
—
—
0
0
36
277
0.82
0.50
1.1
1.2
—
—
—
0
0
7
69
0.64
0.50
1.3
1.2
—
—
—
0
0
319
1904
1.06
0.50
6.3
6.0
12.0
11.6
mg/l
0.67
301
1738
59
322
1.16
0.50
2.8
3.0
—
—
—
0
0
28
221
0.80
0.50
1.3
1.5
11.4
9.8
ug/l
0.68
28
221
109
621
1.12
0.49
3.4
4.2
200.9
159.3
nmol/l
0.32
109
614
152
1055
0.91
0.49
1.1
1.1
—
—
—
0
0
17
80
1.35
0.48
6.2
3.9
—
—
—
0
0
159
1100
0.92
0.48
1.3
1.2
3.8
3.9
u/ml
0.03
70
532
85
607
0.89
0.47
1.4
1.4
65.6
63.1
%
0.29
67
490
11
48
1.46
0.46
1.0
1.0
5.5
5.9
mmol/l
0.21
11
34
56
410
0.87
0.46
5.1
5.6
73.2
70.8
%
0.31
46
337
74
531
0.88
0.45
1.4
1.4
—
—
—
0
0
23
115
1.27
0.45
1.1
1.2
—
—
—
0
0
1250
7720
1.03
0.45
2.1
2.4
168.9
182.7
ug/g
0.50
952
6161
356
2384
0.95
0.45
1.6
1.6
—
—
—
0
0
68
490
0.88
0.45
1.1
1.1
—
—
—
0
0
68
490
0.88
0.45
1.1
1.1
—
—
—
0
0
9
83
0.69
0.44
1.2
1.3
4780.6
1321.6
u/l
—
9
69
14
65
1.37
0.44
1.7
1.6
0.6
0.7
umol/l
—
6
54
16
133
0.76
0.44
1.1
1.2
57.3
102.7
ug/l
—
9
84
6
60
0.63
0.43
1.0
1.1
—
—
—
0
0
416
2770
0.95
0.43
1.2
1.2
—
—
—
0
0
507
3083
1.05
0.43
1.6
1.6
—
—
—
0
0
113
788
0.91
0.43
1.1
1.2
80.2
38.4
u/ml
—
5
41
0
11
0.00
0.42
0.0
1.3
—
—
—
0
0
182
1074
1.08
0.42
1.5
1.7
—
—
—
0
0
182
1074
1.08
0.42
1.5
1.7
—
—
—
0
0
182
1074
1.08
0.42
1.5
1.7
—
—
—
0
0
91
520
1.11
0.42
1.3
1.3
3.7
3.8
mmol/l
0.01
81
475
21
167
0.80
0.41
1.3
1.1
17.9
16.7
u/l
0.14
14
107
160
940
1.08
0.41
1.3
1.3
277.4
280.8
mosm/kgh2o
0.85
124
741
51
372
0.87
0.41
1.1
1.2
1.2
1.1
ratio
0.73
15
115
30
229
0.83
0.41
1.5
1.3
0.8
0.9
mmol/l
0.06
19
152
69
493
0.89
0.41
1.1
1.1
—
—
—
0
0
69
493
0.89
0.41
1.1
1.1
—
—
—
0
0
26
201
0.82
0.40
1.4
1.3
281.6
183.9
titre
—
5
22
7
68
0.65
0.40
2.3
2.2
—
—
—
0
0
69
492
0.89
0.40
1.1
1.1
—
—
—
0
0
10
88
0.72
0.39
1.9
2.1
17.7
17.7
umol/l
—
10
88
9
41
1.39
0.39
2.1
1.5
0.8
2.4
%
—
9
41
11
50
1.40
0.39
1.2
1.1
4.0
1.0
u/field
—
6
29
17
137
0.79
0.38
1.3
1.8
—
—
—
0
0
8
72
0.71
0.38
1.1
1.1
—
—
—
0
0
9
43
1.33
0.38
1.1
1.1
190.7
340.6
u/l
—
9
36
36
267
0.86
0.37
1.2
1.1
101.3
98.4
%
0.17
26
212
45
248
1.15
0.37
1.1
1.1
—
—
—
0
0
204
1217
1.06
0.37
1.6
1.8
—
—
—
0
0
27
142
1.21
0.36
1.1
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
19
150
0.80
0.36
1.1
1.3
84.9
73.4
%
—
8
71
36
195
1.17
0.36
1.5
1.2
50.3
69.8
mu/l
0.45
27
139
166
1128
0.93
0.36
1.3
1.2
4.4
3.9
u/ml
0.11
59
415
258
1552
1.06
0.36
1.4
1.3
488.3
540.8
u/l
0.15
243
1471
25
191
0.83
0.36
1.1
1.1
81.4
80.3
%
0.05
13
123
16
79
1.29
0.36
1.1
1.1
11.8
10.8
u/l
0.07
16
79
210
1256
1.06
0.35
1.4
1.3
14.4
14.5
u/l
0.02
192
1172
34
252
0.86
0.35
1.1
1.1
—
—
—
0
0
357
2168
1.05
0.35
1.3
1.5
—
—
—
0
0
530
3246
1.04
0.35
2.3
2.5
0.0
0.0
g/l
0.00
479
2988
2101
13116
1.02
0.34
8.1
8.5
—
—
—
0
0
764
4711
1.03
0.34
1.3
1.3
61.7
56.4
au/ml
0.19
34
200
62
439
0.90
0.34
1.4
1.3
1.3
1.4
g/l
—
6
34
119
699
1.08
0.34
1.6
1.7
76.3
77.2
umol/l
—
6
41
1525
9492
1.02
0.33
3.3
3.4
4.5
4.6
kpa
0.42
1476
9130
50
358
0.89
0.33
1.7
2.0
—
—
—
0
0
64
365
1.11
0.33
1.3
1.3
—
—
—
0
0
103
709
0.92
0.33
1.1
1.2
—
—
—
0
0
45
251
1.14
0.32
1.0
1.1
—
—
—
0
0
249
1663
0.95
0.32
1.1
1.1
—
—
—
0
0
164
1109
0.94
0.32
1.1
1.2
30.5
43.3
u/ml
—
6
93
209
1255
1.06
0.32
1.4
1.5
5.3
4.1
iu/l
0.42
49
351
57
404
0.90
0.32
1.1
1.2
78.4
50.0
%
—
5
41
20
154
0.82
0.32
1.3
1.3
53.0
48.0
%
—
9
51
297
1973
0.96
0.32
1.2
1.2
—
—
—
0
0
41
296
0.88
0.31
1.4
1.3
37.5
32.1
%
0.34
28
196
91
628
0.92
0.31
2.5
2.8
30.7
34.9
%
0.82
30
205
10
84
0.76
0.31
1.1
1.0
—
—
—
0
0
185
1109
1.06
0.31
1.8
1.3
231.4
249.3
pmol/l
0.47
141
799
101
693
0.92
0.30
1.8
2.0
19.0
16.1
%
0.80
38
257
65
455
0.91
0.30
1.4
1.2
—
—
—
0
0
34
187
1.15
0.30
1.2
1.2
—
—
—
0
0
297
1806
1.04
0.29
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
71
494
0.91
0.29
1.1
1.1
—
—
—
0
0
318
1937
1.04
0.29
1.3
1.4
—
—
—
0
0
8
71
0.72
0.29
1.3
1.3
—
—
—
0
0
19
99
1.22
0.29
1.1
1.0
—
—
—
0
0
577
3556
1.03
0.29
2.2
2.4
0.1
0.0
g/l
0.65
520
3237
154
921
1.06
0.28
1.3
1.3
—
—
—
0
0
192
1157
1.05
0.28
1.6
1.8
—
—
—
0
0
38
273
0.88
0.28
1.0
1.3
14.2
20.0
umol/l
0.46
30
196
33
239
0.88
0.27
1.0
1.2
—
—
—
0
0
96
656
0.93
0.27
1.8
2.0
—
—
—
0
0
32
177
1.15
0.27
1.2
1.2
—
—
—
0
0
105
622
1.07
0.26
2.4
2.5
520.8
520.9
e6/l
0.00
89
533
22
118
1.18
0.26
1.1
1.5
0.4
0.4
ug/l
0.17
15
74
397
2438
1.03
0.26
3.0
2.9
0.8
0.8
nmol/l
0.26
282
1853
536
3308
1.03
0.26
2.3
2.5
0.0
0.0
g/l
0.87
481
2999
15
116
0.82
0.26
1.3
2.7
—
—
—
0
0
56
323
1.10
0.26
1.4
1.4
0.1
0.1
nmol/l
0.32
44
267
138
928
0.94
0.25
1.2
1.1
7.4
7.9
mmol/l
0.73
92
650
12
60
1.27
0.25
1.0
1.2
—
—
—
0
0
257
1700
0.96
0.25
1.3
1.3
—
—
—
0
0
286
1747
1.04
0.25
1.3
1.4
—
—
—
0
0
10
81
0.78
0.25
1.1
1.0
—
—
—
0
0
13
66
1.25
0.25
1.1
1.2
2.0
2.0
umol/24h
0.01
13
66
6
53
0.72
0.24
1.0
1.0
—
—
—
0
0
66
385
1.09
0.24
1.5
1.7
2175.2
17302.4
u/ml
—
6
65
6
55
0.69
0.24
1.2
1.0
—
—
—
0
0
5
23
1.38
0.24
1.0
1.2
—
—
—
0
0
73
500
0.93
0.23
3.2
3.9
13.2
13.3
%
0.57
73
493
85
503
1.07
0.23
1.2
1.3
69.6
269.0
ug/l
1.44
44
256
19
102
1.18
0.23
1.1
1.1
—
—
—
0
0
66
453
0.92
0.22
1.1
1.6
—
—
—
0
0
287
1759
1.04
0.22
1.3
1.5
—
—
—
0
0
0
8
0.00
0.22
0.0
1.5
—
—
—
0
0
64
376
1.08
0.21
1.3
1.2
42.6
40.6
g/l
0.51
35
203
24
133
1.15
0.21
8.5
9.0
0.3
0.3
umol/l
0.17
24
122
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
92
620
0.94
0.20
1.4
1.4
14.8
15.2
umol/l
0.18
85
576
239
1572
0.96
0.20
1.1
1.2
—
10.8
—
0
17
31
176
1.12
0.20
1.2
1.3
3527.4
147.9
ng/l
0.53
17
127
4784
30177
1.01
0.20
2.9
3.1
6504.7
5169.3
umol/l
0.89
3980
26041
363
2241
1.03
0.20
1.5
1.5
31.2
32.3
g/l
0.96
309
2024
221
1453
0.97
0.19
1.1
1.2
3.6
5.6
u/ml
0.29
11
115
87
521
1.06
0.18
2.0
4.9
57.2
1159.5
mg/l
1.10
60
380
12
63
1.21
0.18
1.1
1.3
1.3
1.3
%
0.26
12
63
26
147
1.12
0.18
1.5
1.6
28.0
50.2
pmol/l
1.55
21
119
68
460
0.94
0.17
1.5
1.3
4.2
1.3
u/ml
0.99
39
275
5
42
0.76
0.17
1.0
1.0
—
—
—
0
0
99
597
1.05
0.17
2.4
2.5
0.2
0.2
e9/l
0.03
89
535
13
97
0.85
0.17
2.8
1.1
—
—
—
0
0
102
617
1.05
0.16
1.2
1.5
—
—
—
0
0
23
130
1.12
0.16
3.1
3.3
1.3
1.2
mg/l
0.15
14
110
29
203
0.91
0.16
1.1
1.2
—
—
—
0
0
253
1653
0.97
0.16
1.1
1.2
2.5
7.0
u/ml
0.93
16
167
32
185
1.10
0.16
1.0
1.2
—
—
—
0
0
9
49
1.17
0.15
9.6
10.0
—
—
—
0
0
102
618
1.05
0.15
1.2
1.5
—
—
—
0
0
38
222
1.09
0.15
1.2
1.3
—
—
—
0
0
256
1671
0.97
0.15
1.1
1.2
3.9
6.9
u/ml
1.28
24
243
30
209
0.91
0.15
1.1
1.1
—
—
—
0
0
67
401
1.06
0.15
1.4
1.4
14.9
23.6
%
2.24
53
335
77
463
1.06
0.15
1.3
1.2
—
—
—
0
0
1320
8287
1.01
0.15
8.6
9.8
94.2
93.6
%
3.38
1315
8256
24
169
0.90
0.15
1.4
1.3
—
—
—
0
0
7
56
0.79
0.15
1.0
1.1
36.1
36.9
%
—
7
49
7
56
0.79
0.15
1.0
1.1
20.4
21.7
%
—
7
49
7
56
0.79
0.15
1.0
1.0
8.4
8.8
%
—
7
49
73
489
0.95
0.15
1.1
1.2
—
—
—
0
0
35
241
0.92
0.14
1.1
1.1
—
—
—
0
0
180
1107
1.03
0.14
1.6
1.4
24.3
24.4
%
0.00
106
742
243
1502
1.03
0.14
1.4
1.4
6.1
6.3
mmol/l
0.46
213
1391
27
156
1.10
0.14
1.2
1.2
—
—
—
0
0
10
75
0.85
0.13
1.0
1.1
—
—
—
0
0
927
5814
1.01
0.13
2.8
2.9
1.2
1.2
%
0.62
918
5788
753
4845
0.99
0.13
2.6
2.8
—
—
—
0
0
1308
8226
1.01
0.12
6.6
7.8
24.4
24.4
mmol/l
0.17
1207
7713
23
160
0.91
0.12
3.7
4.9
37.6
57.7
ug/min
1.31
17
140
172
1062
1.03
0.12
3.3
3.1
42.4
65.7
mg/l
0.98
128
815
292
1816
1.02
0.12
1.5
1.5
76740.5
64229.2
e6/l
0.18
184
1125
33
195
1.07
0.11
1.1
1.1
—
—
—
0
0
32
218
0.93
0.11
1.5
1.3
33.9
226.1
u/l
0.65
22
162
36
244
0.94
0.11
1.1
1.1
—
—
—
0
0
77
469
1.04
0.11
1.3
1.2
—
—
—
0
0
531
3418
0.99
0.11
3.0
3.5
4.4
4.4
pmol/l
0.58
467
3057
53
354
0.95
0.10
1.1
1.1
1.1
1.1
u/l
0.06
26
179
50
334
0.95
0.10
1.1
1.1
—
—
—
0
0
496
3107
1.01
0.10
1.8
2.4
3.8
3.7
g/l
1.38
468
2981
116
759
0.97
0.10
2.3
2.5
502.8
559.9
e6/l
0.50
54
311
37
249
0.94
0.09
1.1
1.1
—
—
—
0
0
38
228
1.06
0.09
1.2
1.1
—
—
—
0
0
90
590
0.97
0.09
2.3
2.4
—
—
—
0
0
61
372
1.04
0.08
1.1
1.1
410.6
780.8
ng/l
0.56
21
96
37
248
0.95
0.08
1.1
1.1
—
—
—
0
0
55
364
0.96
0.08
1.1
1.2
—
—
—
0
0
10
72
0.88
0.08
1.2
1.1
8.5
11.5
mmol/l
—
5
37
7
41
1.08
0.08
1.0
1.0
—
—
—
0
0
34
204
1.06
0.08
1.4
1.2
—
—
—
0
0
352
2265
0.99
0.08
1.2
1.2
—
—
—
0
0
1209
7625
1.01
0.08
3.6
3.6
126.5
129.5
g/l
4.25
1175
7437
43
286
0.95
0.08
1.1
1.1
1489.1
1598.7
miu/ml
0.23
43
286
6
47
0.81
0.08
1.0
1.5
—
—
—
0
0
6
48
0.79
0.07
1.0
1.0
—
—
—
0
0
8
48
1.06
0.07
1.0
1.0
—
—
—
0
0
317
1986
1.01
0.07
1.5
1.5
1859.7
2857.9
e6/l
0.88
231
1461
9
53
1.08
0.07
1.1
1.5
—
—
—
0
0
80
523
0.97
0.07
1.3
1.4
2.8
2.6
%
0.12
66
431
436
2798
0.99
0.07
1.0
1.1
—
—
—
0
0
43
285
0.96
0.07
1.1
1.1
—
—
—
0
0
47
310
0.96
0.06
1.2
1.4
52.2
44.0
g/l
0.09
41
236
18
106
1.08
0.06
1.0
1.1
—
—
—
0
0
355
2278
0.99
0.06
1.2
1.2
—
—
—
0
0
63
412
0.97
0.06
1.1
1.1
—
—
—
0
0
76
470
1.03
0.06
1.1
1.1
359.2
370.0
mg/l
0.12
61
417
33
219
0.96
0.05
1.3
1.4
21.1
25.3
%
0.34
23
167
69
450
0.97
0.05
1.1
1.1
—
—
—
0
0
914
5771
1.01
0.05
4.5
4.3
47.0
47.6
%
0.31
903
5700
151
974
0.98
0.05
1.5
1.8
—
—
—
0
0
53
347
0.97
0.05
2.0
2.2
42.4
44.5
u/l
0.04
48
318
189
1184
1.01
0.05
1.4
1.4
12.7
13.3
u/l
0.66
181
1139
35
231
0.96
0.05
1.1
1.2
—
—
—
0
0
17
115
0.94
0.04
1.1
1.1
—
—
—
0
0
26
158
1.04
0.04
1.0
1.1
—
—
—
0
0
897
5672
1.00
0.04
2.8
2.9
0.7
0.7
%
0.67
854
5463
830
5248
1.00
0.03
2.4
2.4
36.3
27.0
au/ml
0.45
25
167
992
6276
1.00
0.03
3.9
3.8
24.9
25.0
mmol/l
0.26
961
6084
47
291
1.03
0.03
1.1
1.0
23.0
9.7
iu/ml
—
7
72
11
75
0.93
0.02
4.2
3.7
—
—
—
0
0
45
292
0.98
0.02
1.2
1.3
168.2
140.1
nmol/l
0.27
32
224
27
166
1.03
0.02
1.0
1.1
—
—
—
0
0
58
362
1.02
0.02
1.4
1.3
11.9
12.8
u/l
0.19
47
294
61
381
1.02
0.02
1.4
1.6
61.4
89.8
umol/l
1.01
25
191
30
196
0.97
0.02
1.6
1.4
71.3
70.0
%
0.08
25
159
23
141
1.04
0.01
1.2
1.2
0.7
0.7
umol/24h
0.06
13
66
30
195
0.98
0.01
1.1
1.2
170.5
11.0
mg/l
0.45
23
148
39
243
1.02
0.01
1.4
1.5
8.0
9.0
%
0.14
20
113
480
3042
1.00
0.00
2.7
2.9
1.8
1.7
mg/l
0.93
431
2739
29
180
1.02
0.00
1.2
1.3
—
—
—
0
0
23
150
0.97
0.00
1.6
1.5
—
—
—
0
0
18
112
1.02
0.00
1.1
1.1
—
—
—
0
0
13
81
1.02
0.00
1.2
1.1
—
—
—
0
0
10
63
1.01
0.00
1.1
1.1
—
—
—
0
0
24
154
0.99
0.00
1.2
1.2
—
—
—
0
0
66
420
1.00
0.00
1.1
1.1
—
—
—
0
0
47
295
1.01
0.00
1.1
1.0
—
—
—
0
0
17
110
0.98
0.00
4.4
4.0
—
—
—
0
0
36
230
0.99
0.00
1.4
1.6
—
—
—
0
0
202
1281
1.00
0.00
1.4
1.5
—
—
—
0
0
19
121
1.00
0.00
1.4
1.5
—
—
—
0
0
88
559
1.00
0.00
1.0
1.1
—
—
—
0
0
35
221
1.01
0.00
1.3
1.1
313.8
231.5
pmol/l
0.57
23
163
11
72
0.97
0.00
1.1
1.2
364.7
354.5
umol/24h
0.04
11
72
39
251
0.99
0.00
1.2
1.1
—
—
—
0
0
79
500
1.00
0.00
1.1
1.1
53.0
55.0
mg/l
0.11
62
427
78
495
1.00
0.00
1.0
1.1
4.5
6.5
nmol/l
0.39
17
113
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
47
0.95
0.00
1.0
1.1
242.3
236.0
nmol/l
—
7
47
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MALE_GENITAL – malignant neoplasm of male genital organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).